BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND RPL22, EAP, 6146 AND Treatment
9 results:

  • 1. A primary pediatric acute myelomonocytic leukemia with t(3;21)(q26;q22): A case report.
    Duan JX; Liu F; Chang L; Che GL; Yang QX; Teng J; Jian H; Liu XJ; Lai SY
    Medicine (Baltimore); 2023 Oct; 102(43):e35721. PubMed ID: 37904382
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study.
    Boissel N; Chiaretti S; Papayannidis C; Ribera JM; Bassan R; Sokolov AN; Alam N; Brescianini A; Pezzani I; Kreuzbauer G; Zugmaier G; FoĆ  R; Rambaldi A
    Blood Cancer J; 2023 Jan; 13(1):2. PubMed ID: 36599847
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Report of an international expanded access program of imatinib in adults with Philadelphia chromosome positive leukemias.
    Capdeville R; Krahnke T; Hatfield A; Ford JM; Van Hoomissen I; Gathmann I
    Ann Oncol; 2008 Jul; 19(7):1320-1326. PubMed ID: 18344535
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
    Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia.
    Cherry AM; Bangs CD; Jones P; Hall S; Natkunam Y
    Cancer Genet Cytogenet; 2001 Sep; 129(2):155-60. PubMed ID: 11566347
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Rearrangements of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: in vitro and in vivo studies.
    Zent C; Rowley JD; Nucifora G
    Leukemia; 1997 Apr; 11 Suppl 3():273-8. PubMed ID: 9209363
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The chimeric genes AML1/MDS1 and AML1/eap inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties.
    Zent CS; Mathieu C; Claxton DF; Zhang DE; Tenen DG; Rowley JD; Nucifora G
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1044-8. PubMed ID: 8577711
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. t(3;21)(q26;q22) with AML1 rearrangement in a de novo childhood acute monoblastic leukaemia.
    Johansson B; Fioretos T; Garwicz S; Heim S; Mitelman F
    Br J Haematol; 1996 Feb; 92(2):429-31. PubMed ID: 8603012
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
    Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
    Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.